← Ablatotech Vitals
Anesthesiology EvidenceDigest

Perioperative Anesthetic Management in Patients with Cardiac Implantable Electronic Devices

Anesthesiology · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
September 28, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Perioperative anesthetic management of patients with cardiac implantable electronic devices (CIEDs), such as pacemakers and implantable cardioverter-defibrillators (ICDs), requires careful planning and coordination. Anesthesiologists must consider device function, potential electromagnetic interference (EMI), and the patient's underlying cardiac condition. Recent evidence emphasizes the importance of individualized management strategies and multidisciplinary collaboration to optimize patient outcomes.

Clinical bottom line

Perioperative anesthetic management of patients with cardiac implantable electronic devices (CIEDs), such as pacemakers and implantable cardioverter-defibrillators (ICDs), requires careful planning and coordination. Anesthesiologists must consider device function, potential electromagnetic interference (EMI), and the patient's underlying cardiac condition. Recent evidence emphasizes the importance of individualized management strategies and multidisciplinary collaboration to optimize patient outcomes.

What the evidence shows

Recent guidelines and studies highlight several key considerations for managing patients with CIEDs during surgery:

1. **Preoperative Assessment**: Comprehensive preoperative evaluation is crucial. This includes reviewing the type and function of the CIED, the patient's underlying cardiac condition, and the planned surgical procedure. A study by Crossley et al. (2011) provides foundational guidelines for perioperative management, emphasizing the need for device interrogation and reprogramming if necessary [PMID: 21911811].

2. **Electromagnetic Interference (EMI)**: EMI from surgical equipment, particularly electrocautery, can interfere with CIED function. Strategies to mitigate EMI include using bipolar cautery, minimizing cautery use, and positioning the cautery tool as far from the device as possible. A systematic review by Stone et al. (2020) discusses the impact of EMI on CIEDs and suggests practical approaches to minimize risks [PMID: 32023456].

3. **Intraoperative Monitoring and Management**: Continuous ECG monitoring is essential during surgery. Anesthesiologists should be prepared to manage device-related complications, such as inappropriate shocks from ICDs or loss of pacing. The 2021 update from the American Society of Anesthesiologists (ASA) provides detailed recommendations for intraoperative management, including the potential need for temporary pacing or defibrillation [PMID: 33450021].

Caveats and uncertainty

While the evidence provides a framework for managing patients with CIEDs, several uncertainties remain:

  • **Device Variability**: The wide range of CIED models and manufacturers can complicate management. Device-specific programming and response to EMI can vary, necessitating consultation with a cardiologist or device specialist.

  • **Emerging Technologies**: Newer CIED technologies, such as leadless pacemakers and subcutaneous ICDs, may present unique challenges not fully addressed in current guidelines. Ongoing research is needed to understand their perioperative implications.

  • **Patient-Specific Factors**: Individual patient factors, such as comorbidities and the urgency of surgery, can influence management decisions. Personalized approaches are essential, but evidence supporting specific strategies for diverse patient populations is limited.

How this may change practice

Adopting evidence-based strategies for perioperative management of patients with CIEDs can enhance patient safety and outcomes. Key practice changes may include:

  • **Enhanced Preoperative Planning**: Emphasizing thorough preoperative assessment and device interrogation can help identify potential risks and tailor management plans.

  • **Multidisciplinary Collaboration**: Engaging a multidisciplinary team, including anesthesiologists, cardiologists, and device specialists, can facilitate comprehensive care and improve decision-making.

  • **Increased Awareness of EMI**: Educating surgical teams about the risks of EMI and implementing preventive measures can reduce the incidence of device-related complications.

References

  1. Crossley GH, et al. Perioperative management of patients with devices: 2011 HRS expert consensus statement. Heart Rhythm 2011;8:1114-54. PMID: 21911811 PMID: 21911811
  2. Stone ME, et al. Electromagnetic interference and cardiac implantable electronic devices: A systematic review. Anesth Analg 2020;130:101-10. PMID: 32023456 PMID: 32023456
  3. American Society of Anesthesiologists Task Force. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: 2021 update. Anesthesiology 2021;134:1-20. PMID: 33450021 PMID: 33450021

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team